J R Montealegre1, E C Peckham-Gregory2, D Marquez-Do3, L Dillon4, M Guillaud5, K Adler-Storthz6, M Follen7, M E Scheurer2. 1. Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA. Electronic address: jrmontea@bcm.edu. 2. Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA. 3. Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA. 4. Research Service Line, Michael E DeBakey VA Medical Center, Houston, TX, USA. 5. Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada. 6. Department of Diagnostic and Biomedical Sciences, University of Texas School of Dentistry, Houston, TX, USA. 7. Department of Obstetrics and Gynecology, Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.
Abstract
OBJECTIVE: HPV genotype distribution varies by race/ethnicity, but is unclear whether there are racial/ethnic variations in HPV 16/18 integration in the host genome. We describe HPV16/18 infection and integration status in a racially/ethnically diverse sample of women with a recent abnormal Pap test. METHODS: Patients (n=640) represent a subset of women participating in a clinical trial. Cervical swabs were tested for HPV16/18 DNA using type-specific polymerase chain reaction assays. Viral integration status was assessed using type-specific integration assays and categorized as fully integrated, fully non-integrated, or mixed. Unconditional logistic regression was used to generate unadjusted (OR) and adjusted odds ratios (aOR) to assess the association between self-reported race/ethnicity and risk of these outcomes. RESULTS: Hispanic and non-Hispanic black women had half the odds of prevalent HPV16 compared to non-Hispanic white women (aORs: 0.43 and 0.45, respectively). The prevalence odds of HPV18 was less than half among Hispanic women (aOR: 0.48), but not significantly different between black and white women (aOR: 0.72). Among women with prevalent HPV16, the odds of fully integrated viral DNA were significantly higher among black women (aORs: 2.78) and marginally higher among Hispanic women (aOR: 1.93). No racial/ethnic differences were observed for HPV18 DNA integration. CONCLUSIONS: While HPV16 and 18 infections were less prevalent among Hispanic and black women compared to whites, their HPV16 DNA was more likely to be present in a fully integrated state. This could potentially contribute to the higher rates of abnormal cytology and cervical dysplasia observed among Hispanic and black women.
OBJECTIVE:HPV genotype distribution varies by race/ethnicity, but is unclear whether there are racial/ethnic variations in HPV 16/18 integration in the host genome. We describe HPV16/18 infection and integration status in a racially/ethnically diverse sample of women with a recent abnormal Pap test. METHODS:Patients (n=640) represent a subset of women participating in a clinical trial. Cervical swabs were tested for HPV16/18 DNA using type-specific polymerase chain reaction assays. Viral integration status was assessed using type-specific integration assays and categorized as fully integrated, fully non-integrated, or mixed. Unconditional logistic regression was used to generate unadjusted (OR) and adjusted odds ratios (aOR) to assess the association between self-reported race/ethnicity and risk of these outcomes. RESULTS: Hispanic and non-Hispanic black women had half the odds of prevalent HPV16 compared to non-Hispanic white women (aORs: 0.43 and 0.45, respectively). The prevalence odds of HPV18 was less than half among Hispanic women (aOR: 0.48), but not significantly different between black and white women (aOR: 0.72). Among women with prevalent HPV16, the odds of fully integrated viral DNA were significantly higher among black women (aORs: 2.78) and marginally higher among Hispanic women (aOR: 1.93). No racial/ethnic differences were observed for HPV18 DNA integration. CONCLUSIONS: While HPV16 and 18 infections were less prevalent among Hispanic and black women compared to whites, their HPV16 DNA was more likely to be present in a fully integrated state. This could potentially contribute to the higher rates of abnormal cytology and cervical dysplasia observed among Hispanic and black women.
Authors: Carolyn E Banister; Amy R Messersmith; Bo Cai; Lisa B Spiryda; Saundra H Glover; Lucia Pirisi; Kim E Creek Journal: J Infect Dis Date: 2014-07-15 Impact factor: 5.226
Authors: Jane R Montealegre; Indu Varier; Christina G Bracamontes; Laura M Dillon; Martial Guillaud; Andrew G Sikora; Michele Follen; Karen Adler-Storthz; Michael E Scheurer Journal: Ethn Health Date: 2017-09-04 Impact factor: 2.772
Authors: Svetlana Vinokurova; Nicolas Wentzensen; Irene Kraus; Ruediger Klaes; Corina Driesch; Peter Melsheimer; Fjodor Kisseljov; Mattias Dürst; Achim Schneider; Magnus von Knebel Doeberitz Journal: Cancer Res Date: 2008-01-01 Impact factor: 12.701
Authors: Marla J Keller; Robert D Burk; L Stewart Massad; Isam-Eldin Eltoum; Nancy A Hessol; Kathryn Anastos; Xianhong Xie; Howard Minkoff; Xiaonan Xue; Laura L Reimers; Mark Kuniholm; Gypsyamber DʼSouza; Christine Colie; Bradley Aouizerat; Joel M Palefsky; Howard D Strickler Journal: AIDS Date: 2018-11-28 Impact factor: 4.632
Authors: Natália L Kops; Jaqueline D C Horvath; Marina Bessel; Flavia M A Souza; Adele S Benzaken; Gerson F M Pereira; Luisa L Villa; Eliana M Wendland Journal: Prev Med Rep Date: 2021-01-05
Authors: Megan A Clarke; Carolann Risley; Mary W Stewart; Kim R Geisinger; Laree M Hiser; Jody C Morgan; Kenyata J Owens; Krishna Ayyalasomayajula; Rhonda M Rives; Ashish Jannela; Dianne E Grunes; Lei Zhang; Mark Schiffman; Sarah Wagner; Joseph Boland; Sara Bass; Nicolas Wentzensen Journal: Cancer Med Date: 2021-11-03 Impact factor: 4.452
Authors: Takeo Shibata; Mayumi Nakagawa; Hannah N Coleman; Sarah M Owens; William W Greenfield; Toshiyuki Sasagawa; Michael S Robeson Journal: PLoS One Date: 2021-08-30 Impact factor: 3.240
Authors: Carolann Risley; Mary W Stewart; Kim R Geisinger; Laree M Hiser; Jody C Morgan; Kenyata J Owens; Krishna Ayyalasomayajula; Rhonda M Rives; Ashish Jannela; Dianne E Grunes; Lei Zhang; Mark Schiffman; Nicolas Wentzensen; Megan A Clarke Journal: Prev Med Date: 2021-07-20 Impact factor: 4.018
Authors: Lucy Wanja Karani; Stanslaus Musyoki; Robert Orina; Anthony Kebira Nyamache; Christopher Khayeka-Wandabwa; Benuel Nyagaka Journal: Pan Afr Med J Date: 2020-03-10